{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:43:19Z","timestamp":1713192199973},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,15]]},"DOI":"10.7759\/cureus.58313","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:28:55Z","timestamp":1713191335000},"source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors Associated With Unsuccessful Linkage to Outpatient Hepatitis C Care"],"prefix":"10.7759","author":[{"given":"Carlo","family":"Foppiano Palacios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brianna","family":"Dubose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Schmalzle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0101554","article-title":"The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis","volume":"9","author":"Yehia BR","year":"2014","unstructured":"Yehia BR, Schranz AJ, Umscheid CA, Lo Re V 3rd. The treatment cascade for chronic hepatitis C virus infection in the United States: a systematic review and meta-analysis. PLoS One. 2014, 9:e101554. 10.1371\/journal.pone.0101554","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1302973","article-title":"Hepatitis C in the United States","volume":"368","author":"Holmberg SD","year":"2013","unstructured":"Holmberg SD, Spradling PR, Moorman AC, Denniston MM. Hepatitis C in the United States. N Engl J Med. 2013, 368:1859-61. 10.1056\/NEJMp1302973","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27194","article-title":"HCV treatment as prevention in prison: key issues","volume":"61","author":"Martin NK","year":"2015","unstructured":"Martin NK, Vickerman P, Goldberg D, Hickman M. HCV treatment as prevention in prison: key issues. Hepatology. 2015, 61:402-3. 10.1002\/hep.27194","journal-title":"Hepatology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12338","article-title":"HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact","volume":"22","author":"Martin NK","year":"2015","unstructured":"Martin NK, Foster GR, Vilar J, et al.. HCV treatment rates and sustained viral response among people who inject drugs in seven UK sites: real world results and modelling of treatment impact. J Viral Hepat. 2015, 22:399-408. 10.1111\/jvh.12338","journal-title":"J Viral Hepat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30501","article-title":"The hepatitis C virus care continuum: linkage to hepatitis C virus care and treatment among patients at an urban health network, Philadelphia, PA","volume":"70","author":"Coyle C","year":"2019","unstructured":"Coyle C, Moorman AC, Bartholomew T, Klein G, Kwakwa H, Mehta SH, Holtzman D. The hepatitis C virus care continuum: linkage to hepatitis C virus care and treatment among patients at an urban health network, Philadelphia, PA. Hepatology. 2019, 70:476-86. 10.1002\/hep.30501","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13220","article-title":"Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: findings from a systematic review","volume":"27","author":"Yanes-Lane M","year":"2020","unstructured":"Yanes-Lane M, Dussault C, Linthwaite B, et al.. Using the barriers and facilitators to linkage to HIV care to inform hepatitis C virus (HCV) linkage to care strategies for people released from prison: findings from a systematic review. J Viral Hepat. 2020, 27:205-20. 10.1111\/jvh.13220","journal-title":"J Viral Hepat"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa322","article-title":"Persistent challenges in the hepatitis C virus care continuum for patients in a central Texas public health system","volume":"7","author":"Reader SW","year":"2020","unstructured":"Reader SW, Kim HS, El-Serag HB, Thrift AP. Persistent challenges in the hepatitis C virus care continuum for patients in a central Texas public health system. Open Forum Infect Dis. 2020, 7:ofaa322. 10.1093\/ofid\/ofaa322","journal-title":"Open Forum Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/hex.13400","article-title":"Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: a mixed-methods systematic review","volume":"25","author":"Paisi M","year":"2022","unstructured":"Paisi M, Crombag N, Burns L, et al.. Barriers and facilitators to hepatitis C screening and treatment for people with lived experience of homelessness: a mixed-methods systematic review. Health Expect. 2022, 25:48-60. 10.1111\/hex.13400","journal-title":"Health Expect"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2010.0142","article-title":"Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration","volume":"24","author":"Swan D","year":"2010","unstructured":"Swan D, Long J, Carr O, et al.. Barriers to and facilitators of hepatitis C testing, management, and treatment among current and former injecting drug users: a qualitative exploration. AIDS Patient Care STDS. 2010, 24:753-62. 10.1089\/apc.2010.0142","journal-title":"AIDS Patient Care STDS"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-020-00445-7","article-title":"Housing stability and hepatitis C infection for young adults who inject drugs: examining the relationship of consistent and intermittent housing status on HCV infection risk","volume":"97","author":"Morris MD","year":"2020","unstructured":"Morris MD, Yen IH, Shiboski S, Evans JL, Page K. Housing stability and hepatitis C infection for young adults who inject drugs: examining the relationship of consistent and intermittent housing status on HCV infection risk. J Urban Health. 2020, 97:831-44. 10.1007\/s11524-020-00445-7","journal-title":"J Urban Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac292","article-title":"The impact of supportive housing on liver-related outcomes among persons with hepatitis C virus infection","volume":"226","author":"Miller-Archie SA","year":"2022","unstructured":"Miller-Archie SA, Walters SC, Bocour A, Moore MS, Wiewel E, Singh T, Lim S. The impact of supportive housing on liver-related outcomes among persons with hepatitis C virus infection. J Infect Dis. 2022, 226:S363-71. 10.1093\/infdis\/jiac292","journal-title":"J Infect Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s40615-017-0453-y","article-title":"Assessing racial disparities in HCV infection and care outcomes in a southern urban population","volume":"5","author":"McGonigle K","year":"2018","unstructured":"McGonigle K, Carley T, Hoff C. Assessing racial disparities in HCV infection and care outcomes in a southern urban population. J Racial Ethn Health Disparities. 2018, 5:1052-8. 10.1007\/s40615-017-0453-y","journal-title":"J Racial Ethn Health Disparities"},{"key":"ref13","unstructured":"Hepatitis C testing and treatment interventions for the homeless population in London during the Covid-19 pandemic. outcomes and learning. (2020). Accessed: 08\/09\/2020: http:\/\/ljwg.org.uk\/wp-content\/uploads\/2021\/01\/HCV-testing-in-temporary-accommodation-during-lockdown-December-2020.pdf."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113092","article-title":"HIV-related stigma and non-adherence to antiretroviral medications among people living with HIV in a rural setting","volume":"258","author":"Kalichman SC","year":"2020","unstructured":"Kalichman SC, Katner H, Banas E, Hill M, Kalichman MO. HIV-related stigma and non-adherence to antiretroviral medications among people living with HIV in a rural setting. Soc Sci Med. 2020, 258:113092. 10.1016\/j.socscimed.2020.113092","journal-title":"Soc Sci Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1492","article-title":"Recommendations for implementing hepatitis C virus care in homeless shelters: the stakeholder perspective","volume":"4","author":"Fokuo JK","year":"2020","unstructured":"Fokuo JK, Masson CL, Anderson A, et al.. Recommendations for implementing hepatitis C virus care in homeless shelters: the stakeholder perspective. Hepatol Commun. 2020, 4:646-56. 10.1002\/hep4.1492","journal-title":"Hepatol Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-018-4649-6","article-title":"Race and hepatitis C care continuum in an underserved birth cohort","volume":"34","author":"Kim NJ","year":"2019","unstructured":"Kim NJ, Locke CJ, Park H, Magee C, Bacchetti P, Khalili M. Race and hepatitis C care continuum in an underserved birth cohort. J Gen Intern Med. 2019, 34:2005-13. 10.1007\/s11606-018-4649-6","journal-title":"J Gen Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61097-0","article-title":"Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews","volume":"378","author":"Nelson PK","year":"2011","unstructured":"Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, Degenhardt L. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011, 378:571-83. 10.1016\/S0140-6736(11)61097-0","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000216","article-title":"Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence","volume":"28","author":"Hickman M","year":"2015","unstructured":"Hickman M, De Angelis D, Vickerman P, Hutchinson S, Martin NK. Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence. Curr Opin Infect Dis. 2015, 28:576-82. 10.1097\/QCO.0000000000000216","journal-title":"Curr Opin Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis928","article-title":"Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels","volume":"207 Suppl 1","author":"Grebely J","year":"2013","unstructured":"Grebely J, Oser M, Taylor LE, Dore GJ. Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV\/HIV coinfection: action required at the system, provider, and patient levels. J Infect Dis. 2013, 207 Suppl 1:S19-25. 10.1093\/infdis\/jis928","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25013","article-title":"Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada","volume":"20","author":"Saeed S","year":"2017","unstructured":"Saeed S, Strumpf EC, Moodie EE, et al.. Disparities in direct acting antivirals uptake in HIV-hepatitis C co-infected populations in Canada. J Int AIDS Soc. 2017, 20:10.1002\/jia2.25013","journal-title":"J Int AIDS Soc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2015.05.002","article-title":"Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic hepatitis C care continuum","volume":"26","author":"Meyer JP","year":"2015","unstructured":"Meyer JP, Moghimi Y, Marcus R, Lim JK, Litwin AH, Altice FL. Evidence-based interventions to enhance assessment, treatment, and adherence in the chronic hepatitis C care continuum. Int J Drug Policy. 2015, 26:922-35. 10.1016\/j.drugpo.2015.05.002","journal-title":"Int J Drug Policy"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2010.01411.x","article-title":"Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance","volume":"19","author":"Martinez AD","year":"2012","unstructured":"Martinez AD, Dimova R, Marks KM, Beeder AB, Zeremski M, Kreek MJ, Talal AH. Integrated internist - addiction medicine - hepatology model for hepatitis C management for individuals on methadone maintenance. J Viral Hepat. 2012, 19:47-54. 10.1111\/j.1365-2893.2010.01411.x","journal-title":"J Viral Hepat"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7517-5-8","article-title":"The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users","volume":"5","author":"Norman J","year":"2008","unstructured":"Norman J, Walsh NM, Mugavin J, Stoov\u00e9 MA, Kelsall J, Austin K, Lintzeris N. The acceptability and feasibility of peer worker support role in community based HCV treatment for injecting drug users. Harm Reduct J. 2008, 5:8. 10.1186\/1477-7517-5-8","journal-title":"Harm Reduct J"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2893.2009.01250.x","article-title":"Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals","volume":"17","author":"Treloar C","year":"2010","unstructured":"Treloar C, Newland J, Rance J, Hopwood M. Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals. J Viral Hepat. 2010, 17:839-44. 10.1111\/j.1365-2893.2009.01250.x","journal-title":"J Viral Hepat"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0b013e32834bcb36","article-title":"Management of HCV and HIV infections among people who inject drugs","volume":"6","author":"Grebely J","year":"2011","unstructured":"Grebely J, Tyndall MW. Management of HCV and HIV infections among people who inject drugs. Curr Opin HIV AIDS. 2011, 6:501-7. 10.1097\/COH.0b013e32834bcb36","journal-title":"Curr Opin HIV AIDS"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/235366-risk-factors-associated-with-unsuccessful-linkage-to-outpatient-hepatitis-c-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T14:29:00Z","timestamp":1713191340000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/235366-risk-factors-associated-with-unsuccessful-linkage-to-outpatient-hepatitis-c-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.58313","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,15]]}}}